[Atypical subtrochanteric femur fracture under alendronate therapy in spite of an intramedullar implant]

H-P Sobotta; T Gösling

doi:10.1007/s00113-016-0270-5

[Atypical subtrochanteric femur fracture under alendronate therapy in spite of an intramedullar implant]

Unfallchirurg. 2017 Feb;120(2):171-175. doi: 10.1007/s00113-016-0270-5.

[Article in German]

Authors

H-P Sobotta¹, T Gösling²

Affiliations

¹ Orthopädische Klinik, Herzogin Elisabeth Hospital, Leipziger Straße 24, 38124, Braunschweig, Deutschland. h.sobotta@heh-bs.de.
² Klinik für Unfallchirurgie und Orthopädische Chirurgie, Städtisches Klinikum Braunschweig, Braunschweig, Deutschland.

PMID: 27812727
DOI: 10.1007/s00113-016-0270-5

Abstract

There are a number of case reports about women undergoing long-term bisphosphonate therapy who have suffered an atypical subtrochanteric or femoral shaft fracture due to an inadequate trauma.The present case reports on a patient who underwent a subtrochanteric femur fracture with the inserted AO femur interlocking nail.

Keywords: Atypical femoral fracture; Implant fracture; Osteoporosis; Subtrochanteric fracture; Therapy with alendronate.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Alendronate / adverse effects*
Alendronate / therapeutic use*
Bone Density Conservation Agents / adverse effects
Bone Density Conservation Agents / therapeutic use
Diagnosis, Differential
Female
Fracture Fixation, Intramedullary / instrumentation*
Hip Fractures / chemically induced*
Hip Fractures / prevention & control
Hip Fractures / surgery*
Humans
Treatment Failure
Treatment Outcome

Substances

Bone Density Conservation Agents
Alendronate